F2 and COVID-19: Endothelial dysfunction plays a pivotal role in leading the COVID-19 patient to a hypercoagulable state, with up to 95% of COVID-19 patients presenting with an elevated D-dimer, a prolonged prothrombin time, a low platelet count, and other laboratory abnormalities [11,12].